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Abstract
The molecular basis for the interaction of insulin granules with the cortical cytoskeleton of pancreatic b-cells remains
unknown. We have proposed that binding of the granule protein ICA512 to the PDZ domain of b2-syntrophin anchors
granules to actin filaments and that the phosphorylation/dephosphorylation of b2-syntrophin regulates this association.
Here we tested this hypothesis by analyzing INS-1 cells expressing GFP-b2-syntrophin through the combined use of
biochemical approaches, imaging studies by confocal and total internal reflection fluorescence microscopy as well as
electron microscopy. Our results support the notion that b2-syntrophin restrains the mobility of cortical granules in
insulinoma INS-1 cells, thereby reducing insulin secretion and increasing insulin stores in resting cells, while increasing
insulin release upon stimulation. Using mass spectrometry, in vitro phosphorylation assays and b2-syntrophin
phosphomutants we found that phosphorylation of b2-syntrophin on S75 near the PDZ domain decreases its binding to
ICA512 and correlates with increased granule motility, while phosphorylation of S90 has opposite effects. We further show
that Cdk5, which regulates insulin secretion, phosphorylates S75. These findings provide mechanistic insight into how
stimulation displaces insulin granules from cortical actin, thus promoting their motility and exocytosis.
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Introduction
Glucose-stimulated trafficking of secretory granules of pancre-
atic b-cells is required for sustained insulin secretion [1].
Increasing evidence points to a dual role for the cortical actin
cytoskeleton in regulating the availability of neurosecretory
granules, including insulin granules, for exocytosis [2,3]. Actin
filaments support the short-range movements of granules [4–6],
but they can also restrict the mobility of vesicles and their access to
the plasma membrane [7–9]. Little is known, however, about how
granules interact with the cortical cytoskeleton.
The catalytically inactive receptor protein tyrosine phosphatase
N, also known as islet cell autoantigen 512 (ICA512) or IA-2
[10–12], is an intrinsic membrane protein of secretory granules [13]
which may link granules to actin filaments [14]. Specifically, its
cytoplasmic tail binds to the N-terminal PSD95/Dlg/ZO-1 (PDZ)
domain of b2-syntrophin [15,16], which in turn interacts with F-
actin throughutrophin[17,18].b2-syntrophinisthe prevalent b-cell
isoform of a highly conserved family of 58 kDa modular adapter
proteins, termed the Syntrophins [19,20]. The five syntrophin
isoforms (a1, b1, b2, c1, c2) have a common domain organization.
Their N-terminal region includes a PDZ domain embedded within
a pleckstrin homology (PH1) domain. The C-terminal half contains
a second PH (PH2) domain and the highly conserved syntrophin
unique (SU) domain [21]. The PH2 and SU domains are both
required for binding dystrophin and the dystrophin-related proteins
utrophin and dystrobrevin [22,23], which in turn bind actin [24].
Syntrophins are part of the dystrophin associated protein complex
(DAPC), which links the actin cytoskeleton with the extracellular
matrix (ECM) [25]. The DAPC is also implicated in transmem-
brane signaling [17]. a1- and b2-syntrophins, in particular, bind to
neuronal nitric oxide synthase (nNOS) [26,27], syntrophin-
associated serine/threonine (SAST) kinase [28], stress-activated
protein kinase3 andvoltage-gated Na+ channel (VGSC)[29,30] via
the PDZ domain. Evidence that syntrophins are implicated in
membrane traffic is supported by the finding that knockout of a1-
syntrophin alters the perivascular localization of aquaporin-4-
containing vesicles [31–33].
Previous studies suggested that b2-syntrophin is phosphorylated
at multiple sites in rat insulinoma INS-1 cells and that
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weakens its binding to ICA512 and the anchoring of insulin
granules to microfilaments [16]. Here we tested this hypothesis by
performing extensive imaging and biochemical studies in INS-1
cells.
Results
GFP-b2-syntrophin resembles endogenous
b2-syntrophin
Since primary beta cells are not well suited for in-depth
mechanistic studies, INS-1 cells were chosen as an in vitro model
to gain further insight into the phosphorylation and function of b2-
syntrophin. The expression pattern of b2-syntrophin in INS-1 cells
resembled closely that of rat and mouse pancreatic islets (Fig. S1A).
Previous studies suggested that sustained stimulation of INS-1
cellswith25 mMglucose (highglucose,HG)plus55 mMKCl(high
potassium,HK)altered the electrophoretic pattern of b2-syntrophin
due to changes in the ratio among different phosphorylated species
[16]. However, the low expression of b2-syntrophin precluded a
detailed analysis of its phosphorylation. Therefore we generated
INS-1 cell clones that stably expressed b2-syntrophin N-terminally
fused with GFP (GFP-b2-syntrophin). As endogenous b2-syntro-
phin, GFP-b2-syntrophin was restricted to the cell cortex (Fig. 1A).
b2-syntrophin and GFP-b2-syntrophin displayed a similar complex
electrophoretic pattern (Fig. 1B). Following stimulation with HG,
either alone or together with HK, the signal of the most prominent
species in resting cells was reduced, while the fastest migrating
species was enhanced, conceivably due to dephosphorylation
(Fig. 1B). Stimulation with HG also slightly increased a slower
migrating species, presumably due to phosphorylation. This species
was also enhanced in rat islets stimulated with HG, alone or
together with HK (Fig. S1B). Stimulation with HK alone induced
less prominent changes. Given its resemblance to the endogenous
protein, GFP-b2-syntrophin was exploited to study the phosphor-
ylation and function of b2-syntrophin in INS-1 cells.
b2-syntrophin modulates insulin secretion
First, we analyzed if GFP-b2-syntrophin affects insulin secre-
tion. To this aim we selected three INS-1 cell clones (G1, G6, G8)
in which GFP-b2-syntrophin was stably expressed 1, 1.8 or 2.5
fold more than endogenous b2-syntrophin (not considering the
presumably GFP-b2-syntrophin-derived fragment of ,70 kDa)
(Fig. 2A). These clones were compared to wild type and GFP-
expressing INS-1 cells for insulin content and release. The basal
insulin secretion was decreased, while both insulin content and the
HGHK insulin secretion stimulation index were increased
accordingly to the levels of GFP-b2-syntrophin (Fig. 2B–C and
Table S1A). The expression of GFP alone did not affect any of
these parameters relative to wild type INS-1 cells. Conversely,
,70% knockdown of b2-syntrophin expression by RNA interfer-
ence (RNAi) significantly increased basal insulin secretion
Figure 1. Expression, localization and stimulus-dependent regulation of b2-syntrophin. A) Confocal microscopy for b2-syntrophin in INS-1
cells and for GFP-b2-syntrophin or GFP in transfected INS-1 cells. b2-syntrophin was detected with the pan-syntrophin antibody 1351. White arrows
indicate the enrichment of b2-syntrophin at the cell periphery. Bars: 5 mm. B) Western blots (WB) with anti-syntrophin or anti-GFP antibodies on extracts
of INS-1 cells (left panel) or GFP-b2-syntrophin INS-1 cells (right panel). Cells were previously kept at rest (0 mM glucose, 5 mM KCl) or stimulated with
high (25 mM) glucose and low (5 mM) KCl (HGLK), low (0 mM) glucose and high (55 mM) KCl (LGHK) or high glucose and high KCl (HGHK).
doi:10.1371/journal.pone.0012929.g001
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syntrophin antibody on immunoprecipitates obtained with the same antibody from extracts of INS-1 cells and three INS-1 cell clones (G1, G6 and G8)
stably transfected with GFP-b2-syntrophin. B) Insulin content (IC) and basal insulin secretion (BIS) of INS-1 cells, GFP-b2-syntrophin INS-1 cell clones
G1, G6, G8 and INS-1 cells stably transfected with GFP. C) Insulin secretion Stimulation Index (SI) of INS-1 cells, GFP-b2-syntrophin INS-1 cell clones G1,
G6, G8 and GFP INS-1 cells. D) Immunoblots with anti-syntrophin and anti-c-tubulin antibodies on extracts of INS-1 cells transfected with a scrambled
shRNA (scr shRNA) or an shRNA for the knockdown of b2-syntrophin (b2-syn shRNA). E) IC and BIS of INS-1 cells transfected with b2-syn or scr shRNAs.
F) SI of INS-1 cells transfected with b2-syn or scr shRNAs. n= number of independent experiments; *, p=0.05; **, p=0.01; ***, p=0.005. p-values in B
and C are relative to INS-1 cells, while in E and F they are relative to INS-1 cells transfected with scr shRNA.
doi:10.1371/journal.pone.0012929.g002
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RNAi, while the levels of cellular insulin and the stimulation index
were significantly decreased (Fig. 2D–F and Table S1B). These
effects were specific as they were rescued by the overexpression of
GFP-b2-syntrophin (Table S1B and Fig. S2). An explanation for
these findings is that restraint of granules by b2-syntrophin reduces
their basal exocytosis, thereby increasing insulin stores and their
release upon stimulation.
b2-syntrophin slows the mobility of cortical granules
The cortical actin cytoskeleton influences the recruitment of
granules for exocytosis by preventing their access to the plasma
membrane. Major changes in the assembly of the cortical
cytoskeleton are unlikely to account for the effect of b2-syntrophin
on insulin secretion (Fig. S3A) since the staining pattern of F-actin
in GFP-b2-syntrophin and GFP INS-1 cells were comparable. If
b2-syntrophin restrains cortical granules, its overexpression should
reduce their mobility. To test this hypothesis we used total internal
reflection fluorescence microscopy (TIRFM) to analyze granule
mobility and density near (#200 nm) the plasma membrane
[34,35]. Granules were visualized after stable transfection of INS-1
cells with the granule cargo chromogranin B fused to monomeric
Red Fluorescent Protein 1 (CgB-mRFP1). Co-localization of CgB-
mRFP1 with insulin granules was verified by confocal microscopy
(Fig. S3B). Granule motility was automatically tracked and
quantified with the MotionTracking/Kalaimoscope software
(Fig. 3A–D and Movies S1–S2). In resting and HGHK-stimulated
CgB-mRFP1 INS-1 cells transiently co-expressing GFP-b2-
syntrophin the density of cortical granules was reduced to 42%
and 46% relative to GFP/CgB-mRFP1 INS-1 cells, respectively
(Fig. 3G and Table S2A). However, stimulation with HGHK
reduced the density of cortical granules by ,1.8 fold in both GFP-
b2-syntrophin/CgB-mRFP1 and GFP/CgB-mRFP1 INS-1 cells;
consistent with the hypothesis that b2-syntrophin regulates the
recruitment of granules to the plasma membrane rather than a late
step in exocytosis. Accordingly, the mean speed of granules in
resting GFP-b2-syntrophin/CgB-mRFP1 INS-1 cells was 74%
compared to GFP/CgB-mRFP1 INS-1 cells (Fig. 3E and H and
Table S2B). HGHK stimulation increased granule mobility in
GFP-b2-syntrophin/CgB-mRFP1 INS-1 cells by 120%, while it
did not changed it in GFP/CgB-mRFP1 INS-1 cells (Fig. 3H and
Table S2B).
Further insights into the impact of b2-syntrophin on the kinetics
of granules were obtained by analyzing their average mean square
displacement. An almost linear dependency of the mean-square
displacement is characteristic of vesicles whose motion is not
constrained [36]. This pattern arises from frequent and random
changes in the direction of granule movements. Here, the mean
square displacement (K) is indicated as diffusion coefficient (D) and
K=4D at a slope of linear dependency (Fig. 3F and I, Table S2C).
In resting GFP-b2-syntrophin/CgB-mRFP1 INS-1 cells the
granule diffusion coefficient was reduced to 65% compared to
GFP/CgB-mRFP1 INS-1 cells. This behavior is characteristic of
vesicles with a stronger interaction with the cytoskeleton and
corroborates the hypothesis that b2-syntrophin restrains granule
mobility. Relaxation of this constraint upon stimulation could then
allow granules to move more freely. Accordingly, after stimulation
the granule diffusion coefficient increased to comparable levels in
GFP-b2-syntrophin/CgB-mRFP1 and GFP/CgB-mRFP1 INS-1
cells (Fig. 3I and Table S2C).
We further compared the appearance of granules in control and
GFP-b2-syntrophin INS-1 cells by electron microscopy (Fig. S4).
In GFP-b2-syntrophin INS-1 cells, the number of granules/cell
was increased ,1.8 fold compared to control INS-1 cells
(26.965.8 vs. 14.862.6, p=0.05), while their size was ,1.3 fold
larger (8454065696 nm2 vs. 6717264584 nm2, p=0.02). These
data are consistent with the greater insulin content measured in
GFP-b2-syntrophin INS-1 cells. We also observed that a minor
fraction of granules in resting GFP-b2-syntrophin INS-1 cells
(1.51%) and INS-1 cells (1.63%) were pear-shaped rather than
spheroidal, being their major/minor diameter ratio .1.9 (Fig.
S4A). Oblong granules were also observed in specimen that had
been either fixed by high pressure freezing or processed for
cryoimmunolabeling (Fig. S4A). Intriguingly, in GFP-b2-syntro-
phin INS-1 cells kept in culture media, which contains 11 mM
glucose and sub-maximally stimulates insulin secretion (Fig. S4C),
the percentage of deformed granules increased to 6% compared to
1.8% (p=0.02) in control INS-1 cells (Fig. S4B and Table S3).
Whether this deformed morphology reflects granule transport
remains to be determined.
b2-syntrophin is phosphorylated on four serine sites
Previous data suggested that b2-syntrophin is a phosphoprotein
and that changes in its phosphorylation affect the interaction with
ICA512, and thus granule traffic (Fig. 1B) [16]. The levels of the
top migrating species of immunoprecipitated GFP-b2-syntrophin,
similar to the corresponding species of b2-syntrophin, were
reduced following the treatment of INS-1 cell extracts with
alkaline phosphatase (Fig. 4A). Opposite changes were observed in
INS-1 cells incubated prior to extraction with the phosphatase
inhibitor okadaic acid (Fig. 4A). Immunoprecipitation from
extracts of 32P-labeled GFP-b2-syntrophin INS-1 cells with the
anti-GFP antibody, but not with control IgG, allowed the
autoradiographic detection of multiple 32P-GFP-b2-syntrophin
species, thus formally demonstrating their phosphorylation
(Fig. 4B).
Analysis by nanoflow reversed phase chromatography and
tandem mass spectrometry (nano LC-MS/MS) indicated that
mouse GFP-b2-syntrophin immunoprecipitated from okadaic
acid-treated INS-1 cells was phosphorylated on serine-75 (S75),
-90 (S90), -213 (S213) and -373 (S373) (Fig. 4C), as indepen-
dently observed in another cell type [37]. These serines are all
flanked by proline-rich motifs that are conserved in the human
and the predicted rat paralogue (Fig. S5). In mouse b2-
syntrophin S75, S90 and S213 are adjacent to the PDZ domain
and thus could affect the binding to ICA512, while S373
is located in the SU domain, and thus might regulate the
interaction with utrophin.
To gain insight into the role of their phosphorylation, each of
these serines was independently replaced either with an aspartate
(S/D), to mimic phosphorylation, or an alanine (S/A), to prevent
it. The corresponding GFP-mutants were expressed in INS-1 cells
(Fig. 5A–B and Fig. S6A–B). Similarly to GFP-b2-syntrophin, all
single S/D mutants as well as the S213A mutant and the S75D/
S90D and S75D/S90A double mutants were restricted to the cell
cortex (Fig. 5A and Fig. S6A). The remaining single S/A mutants
as well as the S75A/S90A and S75A/S90D double mutants were
instead diffuse throughout the cytosol. Intriguingly, in cells
expressing the S75A, S90A, and the S75A/S90D mutants the
cortical fluorescence for F-actin and insulin seemed to be reduced
compared to INS-1 and GFP-b2-syntrophin INS-1 cells (Fig. S7
and not shown).
By immunoblotting the pattern of all GFP-b2-syntrophin S/D
mutants was similar to that of GFP-b2-syntrophin, except for the
S75D mutants, which lacked one species (Fig. 5B and Fig. S6B).
Strikingly, all GFP-b2-syntrophin S/A mutants, except S213A and
S75D/S90A, appeared as weak single bands with mobility similar
to that of the fastest migrating species of GFP-b2-syntrophin. The
b2-Syntrophin and Secretion
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of S75, S90 and S373 point to phosphorylation of these sites being
significant, while modulation of S213 seems less relevant.
Especially critical appears to be the phosphorylation/dephosphor-
ylation cycling of S75, as replacement of this serine with either D
or A reduced the SDS-PAGE pattern of the protein to either two
or one species, respectively. Evidence that the S75D/S90A
mutant, but not the S75A/S90D, localizes at the cell cortex and
migrates as two species instead of one further suggests that
regulation of S75 phosphorylation is dominant relative to that of
S90 (Fig. 5B).
b2-syntrophin S75 and S90 phosphorylation modulates
the binding to ICA512, granule mobility and insulin
secretion
We analyzed whether in vitro transcribed-translated His-tagged
wild-type, S/D and S/A b2-syntrophins labeled with 35S-
Figure 3. Granule density and mobility in GFP-b2-syntrophin INS-1 cells. A–D) Frames from TIRFM movies tracking the motion of CgB-
mRFP1
+ granules (red) in resting INS-1 cells expressing GFP (GFP/CgB-mRFP1 INS-1) (A, C) or GFP-b2-syntrophin (GFP-b2-syn/CgB-mRFP1 INS-1)
(B, D). In C and D each blue line shows the motion of an individual CgB-mRFP1
+ granule tracked for 40 sec. Scale bars: 4 mm. E, F) Mean speed
velocity (E) and square displacement (F) of CgB-mRFP1
+ granules in resting INS-1 cells expressing GFP (black) or GFP-b2-syntrophin (red). In F the
green and blue lines show the weighted least square fit of the initial (first 4 sec) mean square displacement points. The mean square displacement
slope of linear dependency is K=4D, where D is the diffusion coefficient in mm
2 sec
21. G) Density of granules expressed as the number of granules/
100 mm
2 in resting (black bars) and stimulated (red bars) GFP/and GFP-b2-syntrophin/CgB-mRFP1 INS-1 cells. H, I) Mean speed velocities (H) and
diffusion coefficients (I) of CgB-mRFP1
+ granules in resting (black bars) or HGHK-stimulated (red bars) INS-1 cells expressing GFP or GFP-b2-
syntrophin. m= number of movies examined for each condition from four independent experiments.
doi:10.1371/journal.pone.0012929.g003
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domain of ICA512 (ICA512601–979) expressed as a GST-fusion
protein in bacteria (Fig. 6A). Quantifications of autoradiograms
indicated that GST-ICA512601–979 pulled down S75A, S90D
and S75A/S90D His-b2-syntrophin more efficiently than S75D,
S90A and S75D/S90A His-b2-syntrophin (Fig. S6C and Table
S4). Mimicking the phosphorylation of S75 and S90 had opposite
effects on the binding to GST-ICA512601–979, while mutations
of S213 and S373 had no effect on it.
Next, variants of mouse b2-syntrophin with substitutions at
serines 75 and 90 were transiently expressed in INS-1 cells to
investigate their impact on insulin content and release (Fig. 6B and
Table S1C). Similarly to the overexpression of GFP-b2-syntrophin,
the overexpression of variants with increased binding to ICA512,
such as S75A, S90D and S75A/S90D, correlated with increased
insulin content relative to control INS-1 cells. Overexpression of the
S75A/S90D mutant correlated also with reduced basal insulin
secretion and increased HGHK stimulated insulin secretion.
Conversely, overexpression of variants with reduced binding to
ICA512, including S75D and S75D/S90A, correlated with the
reduction of both insulin content and stimulated secretion, while
basal insulin secretion was increased. In cells overexpressing the
S90A mutant insulin content was not reduced, but basal secretion
was increased and stimulated secretion was reduced. Finally, no
significant changes ininsulin content andsecretionwereobserved in
cells overexpressing GFP-b2-syntrophin constructs carrying muta-
tions with opposite effects on the binding to ICA512, such as the
S75A/S90A and S75D/S90D mutants (Table S1C).
Analysis by TIRFM further indicated that in resting CgB-
mRFP1 INS-1 cells expressing GFP-b2-syntrophin S75D density
and mobility of cortical granules were significantly increased by
47.6% (p= 1.65E-10) and 18% (p=1.7E-04), respectively, relative
to those expressing GFP-b2-syntrophin (Fig. 6C, D and Table
S2A, B). The diffusion coefficient of granules in resting CgB-
mRFP1 INS-1 cells expressing GFP-b2-syntrophin S75D was also
significantly increased by 26% (p=0.0019) compared to those
expressing GFP-b2-syntrophin (Fig. 6E and Table S2C). Con-
versely, the density and mobility of cortical granules in CgB-
mRFP1 INS-1 cells overexpressing either GFP-b2-syntrophin or
GFP-b2-syntrophin S90D were similarly reduced relative to cells
expressing GFP only. Evidence that overexpression of a b2-
syntrophin phosphomutant with reduced binding to ICA512
correlated with increased mobility of cortical granules in resting
cells is consistent with the hypothesis that phosphorylation of b2-
syntrophin affects the ability of the cortical cytoskeleton to restrain
granules.
Cdk5 phosphorylates b2-syntrophin at S75
S75and S90conformtotheconsensusforphosphorylationbythe
proline-directed kinases Cdk5, which modulates insulin secretion
[38] and Erk 1/2. Thus, we tested whether the Cdk5 inhibitor
roscovitine and the Erk1/2 inhibitor PD98059 affected b2-
syntrophin phosphorylation. Roscovitine, but not PD98059, altered
the electrophoretic pattern of endogenous b2-syntrophin of INS-1
cells and rat pancreatic islets as well as all tested GFP-b2-syntrophin
variants overexpressed in INS-1 cells (Fig. 7A, B, Fig. S8A and not
shown). Upon roscovitine treatment, in particular, the slower
migrating species of the S75D mutant became undetectable.
Moreover, the purified Cdk5/p25 complex phosphorylated in vitro
two slow migrating species of endogenous and GFP-b2-syntrophins
Figure 4. Phosphorylation/dephosporylation of b2-syntrophin. A) Immunoblots with the anti-syntrophin or anti-GFP antibodies following
immunoprecipitations with the same antibodies from extracts of INS-1 and GFP-b2-syntrophin INS-1 cells, respectively. Alkaline phosphatase (AP) was
added to the immunoprecipitates, while okadaic acid (OA) was added before cell extraction. b2-syntrophin species the levels of which are reduced
upon AP treatment are marked with a gray arrow, while black arrows indicated species increased upon OA incubation. B) The two panels on the left
show the autoradiographies of
32P-GFP-b2-syntrophin immunoprecipitated with the rabbit anti-GFP antibody from extracts of GFP-b2-syntrophin
INS-1 cells labeled with
32P kept in culture media. A control immunoprecipitation from the same cells was performed using rabbit control IgG. The
right panel shows the immunoblot with the anti-GFP antibody on the same immunoprecipitated material visualized by autoradiography. C) Domain
structure of b2-syntrophin, including the phosphoserines identified by mass spectrometry. PH= Pleckstrin Homology domain, PDZ = PSD95/Dlg/
ZO-1 domain, SU = Syntrophin Unique domain.
doi:10.1371/journal.pone.0012929.g004
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two b2-syntrophin species, and especially the slowest migrating
form, were increased upon incubation with the Cdk5/p25 complex.
Notably, one of these species phosphorylated by Cdk5/p25 was
selectively missing in the case of the S75D mutant, but not in the
case of the other tested GFP-b2-syntrophin variants (Fig. 7D and
not shown). Taken together, these results demonstrate that Cdk5
phosphorylates b2-syntrophin on S75 and on another site, which
remains to be determined.
To further verify this conclusion, the expression of Cdk5 was
knocked down in control INS-1 cells and in INS-1 cells expressing
GFP-b2-syntrophin or the S75D mutant. Upon reduction of Cdk5
mRNA and protein by .70% the levels of the two slower
migrating species of b2-syntrophin were decreased in comparison
to control cells, while those of the faster migrating species were
increased (Fig. 8A and B). The decrease of the top migrating
species was also significant in the case of GFP-b2-syntrophin
S75D; supporting the possibility that b2-syntrophin contains
additional Cdk5 phosphorylation sites. Furthermore, the pattern
changes induced by the down regulation of Cdk5 were more
pronounced in cells stimulated with HGHK than in resting cells
(Fig. S8B). These results corroborate the conclusion that
stimulation of insulin secretion triggers the Cdk5-dependent
phosphorylation of b2-syntrophin.
Discussion
Knowledge about the interaction of the cortical cytoskeleton with
insulin granules, and secretory granules in general, is rapidly
accumulating. The best-defined complex for this interaction
includes the granule-associated GTPase Rab27 and its effectors
Slac-2c/MYRIP [39,40] and melanophilin [41,42]. Slac-2c/
MYRIP and melanophilin bind to F-actin [42,43] and the motor
protein myosin Va [43,44], which drives the transport of secretory
granules along cortical actin microfilaments [6,45]. Myosin Va has
also be implicated in their anchoring to the plasma membrane [46].
Interaction of the cytoplasmic domain of the granule transmem-
brane protein ICA512 with the multiarm adaptor b2-syntrophin
has been proposed as an additional mechanism for the tethering of
insulin granules to the actin cytocortex [14]. Previous data indicated
that INS-1 cells express several b2-syntrophin species, which
conceivably originate from phosphorylation/dephosphorylation at
various sites [16]. Stimulation of INS-1 cells with HGHK changes
theratio amongb2-syntrophinspecies and modulatesthe bindingof
its PDZ domain to ICA512 [16,47].
Here we demonstrate that multiple b2-syntrophin species are
also present in pancreatic islets and that the expression levels and
phosphorylation state of b2-syntrophin modulate insulin secretion
in INS-1 cells. Specifically, we show that the expression of b2-
Figure 5. Characterization of b2-syntrophin phosphomutants. A) Confocal microscopy images of GFP-b2-syntrophin and mutants with single
or dual replacements of serine (S) 75, 90 and 213 with either aspartate (D) or alanine (A). Bars: 5 mm. B) Expression pattern of GFP-b2-syntrophin
variants in INS-1 cells as detected by western blotting with the anti-GFP antibody.
doi:10.1371/journal.pone.0012929.g005
b2-Syntrophin and Secretion
PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12929Figure 6. Binding of b2-syntrophin phosphomutants to ICA512 and impact on granule density, mobility and insulin secretion. A)
Autoradiography of in vitro transcribed-translated
35S-labeled His-b2-syntrophin (His-b2-syn) S/D and S/A mutants following pull down assay with
GST-ICA512601–979 or GST. B) Insulin content (IC), basal insulin secretion (BIS) and insulin secretion Stimulation Index (SI) of INS-1 cells transfected with
the S75 and S90 GFP-b2-syntrophin mutants. Wild-type and GFP INS-1 cells were used as controls. n= number of independent experiments;
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secretion, while it inversely correlates with basal insulin secretion.
Hence, the overexpression of b2-syntrophin attenuates the
typically ‘‘leaky’’ phenotype of INS-1 cells relative to primary b-
cells [48]. Overexpression of b2-syntrophin was shown to increase
the levels of ICA512 [47]. This observation is in agreement with
the increased number of granules in b2-syntrophin overexpressing
cells.
*, p=0.05; **, p=0.01; ***, p=0.005; p-values of IC, BIS, and SI were calculated relative to those in INS-1 cells. C–E) Density (C), mean speed velocity
(D) and diffusion coefficient (E) of CgB-mRFP1
+ granules in resting INS-1 cells expressing GFP, GFP-b2-syntrophin or the GFP-b2-syntrophin S75D and
S90D phosphomutants. m= number of movies examined for each condition from six independent experiments.
doi:10.1371/journal.pone.0012929.g006
Figure 7. Phosphorylation of endogenous and GFP-b2-syntrophin and the S/D mutants by Cdk5. A) Immunoblots with anti-syntrophin
or anti-GFP antibodies on rat islet extracts (right panel) or immunoprecipitates obtained with the same antibodies from extracts of INS-1 cells (left
panel) or GFP-b2-syntrophin INS-1 cells (middle panel) treated with the Cdk5 inhibitor roscovitine or the Erk1/2 inhibitor PD98059. Asterisks indicate
the b2-syntrophin species sensitive to roscovitine. B) Immunoblots with the anti-GFP antibody on immunoprecipitates obtained with the same
antibody from extracts of INS-1 cells expressing GFP-b2-syntrophin variants and treated with roscovitine. Gray and black arrows point to b2-
syntrophin species the levels of which decreased or increased in response to roscovitine, respectively. C) Autoradiographies and immunoblots of b2-
syntrophin (left panels) and GFP-b2-syntrophin (right panels) immunoprecipitated with anti-syntrophin or anti-GFP antibodies from INS-1 and GFP-
b2-syntrophin INS-1 cells, respectively. Immunoprecipitates were incubated with or without the Cdk5/p25 complex in the presence of
32P-c-ATP. D)
Autoradiography of GFP-b2-syntrophin variants immunoprecipitated with the anti-GFP antibody from GFP-b2-syntrophin INS-1 cells and incubated
with the Cdk5/p25 complex as in C. An asterisk indicates the b2-syntrophin species that is lacking in the GFP-b2-syntrophin S75D mutant.
doi:10.1371/journal.pone.0012929.g007
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short-range movements of granules in resting cells. Greater insulin
stores and reduced granule mobility in resting cellsoverexpressing
b2-syntrophin are consistent with the hypothesis that this protein
tethers granules to the cortical cytoskeleton. Changes in the
phosphorylation of b2-syntrophin in response to glucose stimula-
tion may weaken the anchoring of granules to microfilaments,
thereby enabling a larger number of vesicles to be mobilized and
released. This interpretation is corroborated by the increased
frequency of pear-shaped granules in sub-maximally stimulated,
but not in resting, INS-1 cells overexpressing b2-syntrophin
relative to control cells. This shape may result from the force
applied by a motor to the granule pole proximal to the transport
cable [49-51]. Alternatively, it could reflect the compression
generated by the focal polymerization of actin at the rear end of
moving granules, as it has been previously described for the
transport of endosomes and lysosomes [50,52–55]. In view of these
considerations, it will be especially interesting to assess the
relationship of b2-syntrophin with the machinery for granule
transport. Silencing of myosin Va, similarly to the silencing of
Slac-2c/MYRIP [40], impairs the glucose stimulated recruitment
and exocytosis of insulin granules, although it had no impact on
basal insulin secretion [5]. Slac-2c/MYRIP overexpression led
also to impaired granule mobility and hormone secretion in PC12
cells, whereas a construct lacking the actin-binding domain
increased mobility while still impairing secretion [39]. These data
raised the hypothesis that myosin Va-mediated translocation of
granules only occurs after detachment of Slac-2c/MYRIP from
microfilaments, possibly due to the calpain-mediated cleavage of
Slac-2c/MYRIP actin-binding C-terminus [56]. Intriguingly,
calpain disrupts also the binding of ICA512 to b2-syntrophin,
and thereby to actin [47]. Thus, at least two distinct complexes
regulate the tethering and release of granules from the cortical
cytomatrix. Importantly, regulation of the ICA512/b2-syntrophin
complex by phosphorylation rather than calpain cleavage provides
a mechanism for reversible granule tethering to F-actin.
The density of cortical granules detected by TIRFM in resting
GFP-b2-syntrophin INS-1 cells was reduced relative to resting
cells expressing GFP alone. This observation is only apparently in
contrast with the biochemical and microscopy data indicating that
b2-syntrophin overexpression increases insulin stores and the total
number of granules. Recent independent observations by the
Nagamatsu and the Seino laboratories using a modified set-up for
TIRFM suggests that immobile insulin granules accumulate in a
Figure 8. Expression of b2-syntrophin species upon Cdk5 depletion. A) Immunoblots with anti-syntrophin, anti-Cdk5 and anti-c-tubulin
antibodies on extracts of INS-1 (left panels), GFP-b2-syntrophin INS-1 (middle panels) and GFP-b2-syntrophin S75D INS-1 (right panels) cells following
the knockdown of Cdk5 (Cdk5 shRNA). As control, INS-1 cells were transfected with a scrambled shRNA. Gray and black arrows point to the b2-
syntrophin species the levels of which decreased or increased upon Cdk5-depletion, respectively. The b2-syntrophin species were numbered from
top to bottom B) Quantification of the immunoblots shown in A. p-values are relative to cells transfected with scr shRNA. n= number of experiments.
*, p=0.05; **, p=0.01; ***, p=0.005.
doi:10.1371/journal.pone.0012929.g008
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communication), i.e. at a distance that is beyond the optical depth
of conventional TIRFM (#200 nm). By trapping more granules in
this zone, b2-syntrophin could prevent their access to the region
visualized here by TIRFM. This interpretation, however, does not
explain the reduced mobility of cortical granules in b2-syntrophin
overexpressing cells. To clarify this point, further studies will be
necessary regarding the relationship of b2-syntrophin with the
granule transport machinery.
Our data confirm that b2-syntrophin is a phosphoprotein and
demonstrate that its complex phosphorylation pattern changes in
relation to stimulation of insulin secretion. The conserved S75 and
S90 adjacent to the PDZ domain are especially relevant as these
phosphosites modulate the intracellular compartmentalization of
b2-syntrophin and its interaction with ICA512. Specifically,
phosphorylation of S75 and dephosphorylation of S90 weaken
the binding to ICA512 in vitro. This could account for the reduced
insulin content and increased basal insulin secretion of INS-1 cells
expressing the b2-syntrophin mutants S75D, S90A and S75D/
S90A. Furthermore, overexpression of the b2-syntrophin S75D
phosphomutant, but not b2-syntrophin S90D enhanced the
mobility of cortical granules relative to resting cells overexpressing
b2-syntrophin. These data corroborate the hypothesis that b2-
syntrophin restrains granule mobility at rest and that its
phosphorylation/dephosphosphorylation represents a regulatory
mechanism modulating actin/granule interaction and therefore
insulin secretion. Evidence that all S75A and S90A mutants,
except S75D/S90A, were diffusely distributed in the cytosol rather
than being restricted to the cell cortex further suggest that cyclic
phosphorylation/dephosphorylation of these serines, and especial-
ly of S75, is critical for the proper localization and function of b2-
syntrophin.
We show that Cdk5 phosphorylates b2-syntrophin on S75. In
neurons Cdk5 can either increase or decrease neurotransmitter
release by phosphorylating various proteins implicated in exocy-
tosis of synaptic vesicles, including synapsin I [57], Munc18 [58],
and P/Q type voltage-dependent Ca2+-channels [59]. Cdk5
appears to play contrasting roles in regards to synaptic vesicle
exocytosis [58,59], endocytosis [60,61] and insulin secretion
[62,63]. The stimulatory role of Cdk5 and its activating cofactor
p39 on insulin secretion has been attributed to the phosphoryla-
tion of Munc18 [62], whereas its inhibitory effect has been
ascribed to the phosphorylation of a serine in the ac1 subunit of
the L-type voltage-dependent Ca2+-channels [63], which regulates
the binding of the SNARE proteins syntaxin and SNAP25 to these
channels. As for synaptic vesicle endocytosis [64], these apparently
conflicting roles of Cdk5 in b-cell secretion can be explained in
view of our present findings. Cdk5-mediated phosphorylation of
b2-syntrophin on S75 could indeed enhance insulin secretion by
promoting the mobilization of cortical granules. Dephosphoryla-
tion of S75, on the other hand, would enable the cortical
cytomatrix to recapture granules that did not undergo exocytosis,
thereby retaining them at a favorable distance for recruitment in
the next round of exocytosis.
In conclusion, these data extend and partially revise our
previous model wherein b2-syntrophin affects the traffic and
exocytosis of insulin granules by mediating their anchoring to
the cortical cytoskeleton through its binding to ICA512 [16].
This interaction is dynamically controlled via phosphorylation/
dephosphorylation of b2-syntrophin at multiple serines. Among
them, S75, which is phosphorylated by Cdk5, appears to play a
dominant role both in the cortical localization of b2-syntrophin
and the association with ICA512. Understanding the dynamics
of this interaction will require the structural resolution of the
b2-syntrophin/ICA512 complex as well as the identification of
other kinases, phosphatases and factors that regulate this
association.
Materials and Methods
Islet isolation and Cell culture
Pancreatic islets from female Wistar rats were isolated and
cultured [65] and INS-1 cells were grown [66] as described. Briefly
the islets standard culture medium contained 5.5 mM (islets)
glucose, while the medium for INS-1 cells contained 11 mM
glucose. Unless otherwise stated, INS-1 cells and pancreatic islets
were directly harvested from culture media or incubated for
60 min in resting buffer (0 mM glucose, 5 mM KCl) and then for
120 min in fresh resting or stimulating (25 mM glucose (HG) and/
or 55 mM KCl (HK)) buffer, as described [16]. Cells were treated
for 60 min with 40 mM roscovitine (Alexis Biochemicals), 5 mM
PD98059 (Calbiochem) or 30 min with 1 mM okadaic acid (Alexis
Biochemicals) prior to harvest.
cDNA constructs
The following constructs have been already described: mouse GFP-
b2-syntrophin [18], His-b2-syntrophin [15], GST-ICA512601–979
[15]. Single and double mutants of b2-syntrophin in which serines
S75, 90, 213 and 373 were replaced either individually or in tandem
by aspartate (S/D) or alanine (S/A) were generated using mouse b2-
syntrophins N-terminally fused to GFP or His-tag as templates for
mutagenesis with the QuikChange Multi Site-Directed Mutagenesis
Kit (Stratagene). The oligonucleotides used for mutagenesis are listed
in Table S5A. The human cDNA of the granule cargo chromogranin
B (CgB; gift from W. Huttner, MPI-CBG, Dresden) was fused
in frame at the 59-end of monomeric Red Fluorescent Protein
(mRFP1) cDNA (Planetgene; [67]). All constructs were generated
using conventional procedures and verified by DNA sequencing.
Cell transfections
Electroporation of INS-1 cells and generation of stable GFP-
and GFP-b2-syntrophin INS-1 cell clones were performed as
described [68]. CgB-mRFP1 INS-1 clones were selected for
puromycin resistance, and further screened by fluorescence
microscopy and immunoblotting for expression of the transgene.
Cell extracts, Western blottings
Pancreatic islets and INS-1 cells were washed with ice cold PBS,
and extracted in lysis buffer (PBS pH7.5, 1% Triton X-100, 1 mM
EDTA, 1% protease and phosphatase inhibitor) at 4uC [16].
Protein measurements and immunoblottings were performed as
described [68] using the following primary antibodies: monoclonal
mouse anti-syntrophin 1351 [69], anti-c-tubulin (Sigma) and anti-
Cdk5 (Molecular Probes) antibodies; polyclonal goat (gift from
David Drechsel, MPI-CBG, Dresden) and rabbit (Molecular
Probes) anti-GFP antibodies. Chemiluminescence was developed
and quantified as described [68].
Immunoprecipitation
Protein extracts of INS-1 cells were incubated overnight at 4uC
with one of the following antibodies: anti-syntrophin, goat or
rabbit anti-GFP, goat or rabbit IgGs (Sigma), followed by
incubation with protein G or A sepharose (GE Healthcare
Biosciences) for 120 min. The beads were washed 10 times, and
loaded on a 10% SDS-PAGE followed by western blotting. For
dephosphorylation G sepharose-coupled immunoprecipitates of
endogenous or GFP-b2-syntrophins were equilibrated with
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(Roche) for 1 hour at 37uC.
In vitro phosphorylation
GFP-b2-syntrophin INS-1 cells were pre-incubated for 30 min.
in phosphate-free medium. Cells were equilibrated in phosphate-
free medium containing 25 mCi 32P per dish (0.7 mCi/ml) for
3 hours and immunoprecipitated as described above. Following
western blotting, 32P-labeling of immunoprecipitated GFP-b2-
syntrophin was detected by autoradiography.
In vitro kinase assay
The Cdk5/p25 complex was expressed and purified from Sf9
cells co-infected with baculovirus as described [70]. Phosphoryla-
tion of immunoprecipitated b2-syntrophin from INS-1 cells or
GFP-b2-syntrophin from GFP-b2-syntrophin INS-1 cells or the
transiently expressed phosphomutants in the presence of 10 mCi c-
[32P]ATP was performed as described [71]. Kinase reactions were
stopped by adding SDS-PAGE sample buffer. Samples were
analyzed by western blotting and autoradiography.
Pull-Down Assays
Full-length His-b2-syntrophin constructs were in vitro transcribed-
translated with the T7-coupled transcription/translation system
(Promega). GST and GST-ICA512601–979 were expressed in
bacteria as described [16]. 35S-methionine-labeled His-b2-syntrophin
variants were then equilibrated with 5 mg of GST or GST-ICA601-
979 coupled to glutathione-sepharose beads (GE) and incubated 4 hr
at RT. Beads were washed 10 times with binding buffer and eluted
with 10 mM of reduced glutathione. Eluted proteins were subjected to
SDS-PAGE and analyzed by autoradiography.
RNA interference
The pGENE-CLIP U1 cassette system (Promega) was used
according to the manufacturers instruction to clone short hairpin
(sh)RNAs for Cdk5, GFP, rat b2-syntrophin (b2-syn) or scrambled
(scr) (Table S5B). INS-1 cells were transfected with shRNA by
electroporation as described [68]. Cells were harvested 4 days after
transfection and knockdown of Cdk5 and b2-syntrophin was
measured by qRT-PCR and western blotting [68].
Insulin RIA
Insulin content and secretion were assessed with the Sensitive
Rat Insulin RIA Kit (Linco Research) as described [68]. The
insulin stimulation index was calculated as follows: secreted/total
insulin in stimulated conditions vs. secreted/total insulin in resting
conditions.
Immunocytochemistry
Labeling of transfected or non-transfected INS-1 cells was
performed as described [68]. The following primary and
secondary antibodies were used: anti-syntrophin, mouse anti-
insulin (Sigma), Alexa488- and Alexa568-conjugated goat-anti-
mouse or -rabbit IgGs (Molecular Probes). Phalloidin-rhodamine
(Molecular Probes) was used to visualize actin filaments and nuclei
were counterstained with DAPI (Sigma). Images of 0.5 mm optical
sections were acquired with an inverted confocal microscope LSM
Meta 405 nm (Zeiss) using a 63x oil immersion objective with a
numerical aperture of 1.4.
TIRFM
Prior to TIFM imaging (see Methods S1), INS-1 cells stably
expressing mouse CgB-mRFP1 were grown in an open chamber,
incubated in resting or stimulated media and transferred onto a
thermostat-controlled stage at 37uC. CgB-mRFP1+ granules in
INS-1 cells expressing GFP-b2-syntrophin or GFP were visualized
by excitation of mRFP1 and GFP. Images were collected using the
IQ 1.7 software (Andor Technology) with an exposure time of
40 ms (sequential imaging of GFP and mRFP1, each 20 ms), for a
total of 1200 frames (0.14 sec/frame), each movie in resting or
stimulated conditions. Automated image analysis was performed
with the MotionTracking/Kalaimoscope software (Transinsight
GmbH), as described (Methods S1; [72]). Statistical data for
granule density in GFP/CgB-mRFP1 and GFP-b2-syntrophin/
CgB-mRFP1 cells were obtained from 15 and 17 movies at rest
and 15 and 12 movies in stimulated conditions, respectively (Fig. 3).
For speed measurements the total number of experiments and
tracked CgB-mRFP1+ granules in GFP and GFP-b2-syntrophin/
CgB-mRFP1 cells at resting was 15/18564 and 17/19176 and in
stimulated conditions 5/4367 and 8/4131 (Fig. 3). Statistical data
for granule density or mobility in CgB-mRFP1 INS-1 cells
overexpressing GFP, GFP-b2-syntrophin GFP-b2-syntrophin
S75D or GFP-b2-syntrophin S90D were obtained from 64, 49,
64 or 32 movies at rest, respectively (Fig. 6).
Electron microscopy (EM)
INS-1 cells were subjected to 3 different protocols for EM. In
protocol 1 cells were grown on glass coverslips for four days, fixed
with 1% glutaraldehyde in 0.1 M cacodylate buffer and
processed for standard Epon-embedding [73]. In protocol 2 cells
were grownon sapphire discs and high pressure frozen and freeze
substituted as described [74]. For cryoimmuno EM (protocol 3)
cells were fixed and scraped into a pellet as described [75].
Sections were incubated with anti-insulin (Sigma) antibody
followed by goat anti-mouse IgG conjugated to 12 nm gold
particles (Dianova). Images of cells kept in culture media or
rested for 180 min prior to fixation with aldehydes (protocol 1)
were used for the morphometry analysis of granules. Statistics
was performed with the ImageJ Software (http://rsb.info.nih.
gov/ij/index.html). An ellipse was fitted on the granules, the
major and minor diameters were measured and the number of
granules per cell was counted.
Mass Spectrometry, Phosphomapping
SDS-PAGE separated proteins were subjected to in-gel
digestion as described previously [76]. Automated nanoflow LC
Electrospray-Ionisation (ESI) MS/MS analysis was performed
using a QTOF Ultima mass spectrometer (Waters) employing
automated data dependent acquisition [77]. Raw data was
processed using ProteinLynx Global Server ProteinLynx (V2.0)
into pkl peak list files and searched against the NCBI non-
redundant protein database using an in-house MASCOT server
version 2.0 (Matrix Sciences). The following constraints were
applied: potentially upto two missed cleavage sites were allowed;
60.5 Da tolerance for MS and 60.2 Da for MS/MS fragment
ions; carbamidomethyl cysteine was specified as a fixed modifica-
tion, deamidation (NQ) phosphorylation (S, T, Y) and methionine
oxidation (M) were specified as variable modifications.
Sequence Alignment, Motifscan
Multiple sequence alignments were produced with the program
ClustalW (http://www.ebi.ac.uk/clustalw/) and manually re-
fined. Protein domains of b2-syntrophin were located with
Scanprosite (http://au.expasy.org/tools/scanprosite/) and adapt-
ed from the literature [15,19]. Prediction of kinase binding sites
was performed with http://scansite.mit.edu/motifscan_seq.phtml.
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Quantification of western blots and autoradiographies was
performed using Image Gauge V3.45 (Fuji, Tokyo, Japan). Statistics
was performed using the unpaired Student’s t-test. Results are
presented as mean 6SE from at least three independent experiments.
Histograms were prepared with Microsoft Excel (Microsoft).
Supporting Information
Methods S1
Found at: doi:10.1371/journal.pone.0012929.s001 (0.04 MB
DOC)
Figure S1 Expression pattern of b2-syntrophin in rat INS-1 cells
and in rat and mouse islets. A) Immunoblotting (left panels) with
anti-syntrophin and anti-c-tubulin antibodies on extracts of INS-1
cells, rat and mouse islets kept in their standard culture medium
with either 11 mM (INS-1 cells) or 5.5 mM (islets) glucose.
Quantification (right histogram) of the immunoblots shown on the
left. B) Immunoblotting with anti-syntrophin antibody on INS-1
cells (left panel) and rat islets (right panel). Cells were previously
kept at rest (0 mM glucose, 5 mM KCl) or stimulated with high
(25 mM) glucose and low (5 mM) KCl (HGLK), low (0 mM)
glucose and high (55 mM) KCl (LGHK) or high glucose and high
KCl (HGHK).
Found at: doi:10.1371/journal.pone.0012929.s002 (0.33 MB TIF)
Figure S2 Impact of b2-syntrophin knockdown on insulin
content and secretion. Insulin content (IC), basal insulin release
(BIS) and insulin secretion Stimulation Index (SI) of INS-1 cells
following the depletion of b2-syntrophin by RNA interference (b2-
syn shRNA) and its rescue with GFP-b2-syntrophin. Control cells
were transfected in parallel with a scrambled shRNA, with or
without GFP-b2-syntrophin. n= number of independent exper-
iments; *, p=0.05; **, p=0.01; ***, p=0.005; p-values are
relative to scr shRNA transfected INS-1 cells.
Found at: doi:10.1371/journal.pone.0012929.s003 (0.10 MB TIF)
Figure S3 Colocalization of GFP-b2-syntrophin with F-actin
and of CgB-mRFP1 with insulin. A) Confocal microscopy of GFP
and GFP-b2-syntrophin INS-1 cells labeled with rhodaminated-
phalloidin (pseudored). B) Co-localization of CgB-mRFP1 (pseu-
dored) and insulin (pseudogreen) in stable CgB-mRFP1 INS-1
cells. Bars: 5 mm.
Found at: doi:10.1371/journal.pone.0012929.s004 (2.29 MB TIF)
Figure S4 Granule morphometry in INS-1 cells and GFP-b2-
syntrophin INS-1 cells. A) Electron microscopy images of INS-1
and GFP-b2-syntrophin INS-1 cells kept in culture medium and
fixed with aldehydes (protocols 1 and 3) or by high-pressure
freezing (HPF; protocol 2) followed by Epon-embedding (protocols
1 and 2) or freezing (Cryo; protocol 3) before sectioning.
Aldehyde/cryo specimens were immunogold-labeled with an
anti-insulin antibody. The black dots in the left panels correspond
to immunogold-labeled insulin. White arrowheads point to
granules with a deformed shape. B) Percentage of granules with
a major/minor diameter $1.9 in resting or sub-maximally
stimulated INS 1 and GFP-b2-syntrophin INS-1 cells. Data were
obtained from 2 independent experiments (n). *, p=0.05; C)
Insulin secreted from INS-1 cells and GFP-b2-syntrophin INS-1
cells kept in culture medium, compared to resting and HGHK-
stimulated cells. n= number of independent experiments;
*, p=0.05; **, p=0.01. p-values in are relative to INS-1 cells
and, GFP-b2-syntrophin INS 1 cells kept in culture media.
Found at: doi:10.1371/journal.pone.0012929.s005 (2.82 MB
TIF)
Figure S5 Conservation of phosphoserines in rodent and human
b2-syntrophin. Alignment of the primary amino acid sequences of
mouse (mb2-syn), human (hb2-syn) and predicted rat (rb2-syn) b2-
syntrophin. The split PH1 domain (PH1a, PH1b) of b2-syntrophin
is marked in italic and underlined; the PH2 domain is underlined;
the PDZ domain is boxed, while the SU domain is in italic. The
phosphoserines of mouse b2-syntrophin identified by mass
spectrometry are marked in red, while the isolated phosphopep-
tides are in bold and underlined. The rat b2-syntrophin sequence
was assembled from two in silico sequences (XM_344764,
XP_226430) of the rat genome project. Asterisks mark amino
acids that are identical in mouse and human; double dots mark
conservative changes, while single dots mark semi-conservative
changes.
Found at: doi:10.1371/journal.pone.0012929.s006 (1.54 MB
TIF)
Figure S6 Localization, expression pattern and ICA512-binding
of GFP-b2-syntrophin mutants. A) Confocal microscopy images of
INS-1 cells expressing the indicated single or double GFP-b2-
syntrophin S/D and S/A mutants compared to GFP-b2-syntrophin
and GFP INS-1 cells. Bars: 5 mm. B) Immunoblots with anti-GFP
and c-tubulin antibodies on extracts of INS-1 cells expressing the
GFP-b2-syntrophin variants. The left panel was overexposed
relative to the right panel in order to detect GFP-b2-syntrophin
S75A/S90A and S373A. C) Ratio of in vitro transcribed-translated
35S-His-b2-syntrophin phosphomutants pulled down with GST-
ICA512601–979 relative to
35S-His-b2-syntrophin. n= number of
independent experiments; *, p=0.05; **, p=0.01.
Found at: doi:10.1371/journal.pone.0012929.s007 (0.74 MB
TIF)
Figure S7 Colocalization of GFP-b2-syntrophin variants with
the actin cytoskeleton and insulin. A) Colocalization of b2-
syntrophin and GFP-b2-syntrophin variants with F-actin. B)
Colocalization of b2-syntrophin and GFP-b2-syntrophin variants
with insulin. Bars: 5 mm.
Found at: doi:10.1371/journal.pone.0012929.s008 (2.59 MB TIF)
Figure S8 Impact of Cdk5 on the expression pattern of b2-
syntrophin and GFP-b2-syntrophin variants in resting and
stimulated INS-1 cells. A) Western blotting with anti-GFP, -
syntrophin and -c-tubulin antibodies on extracts from resting and
HGHK-stimulated INS-1 cells (left panels) and INS-1 cells
expressing different GFP-b2-syntrophin variants. Cells were
treated or not with roscovitine prior to extraction. B) Immunoblots
with anti-Cdk5, -GFP, -syntrophin, and -c-tubulin antibodies on
extracts of resting and HGHK-stimulated INS-1 (right panels),
GFP-b2-syntrophin INS-1 (middle panels) and GFP-b2-syntro-
phin S75D INS-1 (left panels) cells following the knockdown of
Cdk5 (Cdk5 shRNA). Control INS-1 cells were transfected with a
scrambled shRNA.
Found at: doi:10.1371/journal.pone.0012929.s009 (0.42 MB TIF)
Table S1 Insulin content and secretion of INS-1 cells relative to
GFP-b2-syntrophin expression and phosphorylation. A) Insulin
content (IC), basal (BIS) and Stimulation Index (SI) of GFP-b2-
syntrophin INS-1 cell clones G1, G6 and G8 compared to INS-1
cells and GFP INS-1 cells. B) IC, BIS and SI of INS-1 cells
transfected with scr shRNA or b2-syn shRNA, with or without
GFP-b2-syntrophin. C) IC, BIS and SI of INS-1 cells and INS-1
cells transiently transfected with GFP or GFP-b2-syntrophin
variants. The data in A, B and C are from 3, 4 and 6 independent
experiments, respectively.
Found at: doi:10.1371/journal.pone.0012929.s010 (1.07 MB
PDF)
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INS-1 cells. A) Density of granules/100 mm
2. B) Granule mean
speed distribution; C) Mean square displacement presented as
diffusion coefficient. The data are from 4 and 6 independent
experiments, respectively.
Found at: doi:10.1371/journal.pone.0012929.s011 (0.97 MB
PDF)
Table S3 Granule morphometry in INS-1 cells and GFP-b2-
syntrophin INS-1 cells. Total number of measured granules,
number and percent of granules with a major/minor granule
diameter $1.9 from INS-1 and GFP-b2-syn INS-1 cells in resting
(R) buffer or in culture media (M).
Found at: doi:10.1371/journal.pone.0012929.s012 (0.21 MB
PDF)
Table S4 Quantification of b2-syntrophin-ICA512 pull-down
assays. Autoradiographic signals of in vitro transcribed-translated
35S-labeled His-b2-syntrophin S/D and S/A mutants recovered
with GST-ICA512601–979 expressed as percentage of pull down
His-b2-syntrophin.
Found at: doi:10.1371/journal.pone.0012929.s013 (0.33 MB
PDF)
Table S5 Primers for A) site-chain-mutagenesis, B) RNAi and C)
qRT-PCR.
Found at: doi:10.1371/journal.pone.0012929.s014 (0.69 MB
PDF)
Movie S1 TIRFM movie tracking the motion of CgB-mRFP1
+
granules in resting INS-1 cells transiently expressing GFP. The
automated tracking of CgB-mRFP1
+ granules is shown in the
left panel of the movie. The signals for GFP and mRFP1 are
separately shown in the middle and right panels, respectively.
Bar =5 mm.
Found at: doi:10.1371/journal.pone.0012929.s015 (6.11 MB
MP4)
Movie S2 TIRFM movie tracking the motion of CgB-mRFP1
+
granules in resting INS-1 cells transiently expressing GFP-b2-
syntrophin. The automated tracking of CgB-mRFP1
+ granules is
shown in the left panel of the movie. The signals for GFP and
mRFP1 are separately shown in the middle and right panels,
respectively. Bar =5 mm.
Found at: doi:10.1371/journal.pone.0012929.s016 (6.11 MB
MP4)
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